US 8399609
Treating or preventing extracellular matrix build-up
granted A61KA61K38/00A61P
Quick answer
US patent 8399609 (Treating or preventing extracellular matrix build-up) held by REGENERX BIOPHARMACEUTICALS, INC. expires Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERX BIOPHARMACEUTICALS, INC.
- Grant date
- Tue Mar 19 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61K, A61K38/00, A61P, A61P7/02, A61P9/00